138 related articles for article (PubMed ID: 38467248)
41. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
[TBL] [Abstract][Full Text] [Related]
42. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.
Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC
Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297
[TBL] [Abstract][Full Text] [Related]
43. Novel three-way complex rearrangement of TRPM1-PUM1-LCK in a case of agminated Spitz nevi arising in a giant congenital hyperpigmented macule.
Goto K; Pissaloux D; Durand L; Tirode F; Guillot B; de la Fouchardière A
Pigment Cell Melanoma Res; 2020 Sep; 33(5):767-772. PubMed ID: 32386465
[TBL] [Abstract][Full Text] [Related]
44. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
van Dijk MC; Bernsen MR; Ruiter DJ
Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
[TBL] [Abstract][Full Text] [Related]
45. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
[TBL] [Abstract][Full Text] [Related]
46. Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus.
Kiyohara T; Takata M; Itoh H; Kawami K; Ido H; Ishida H; Kumakiri M
J Dermatol; 2012 Dec; 39(12):1034-5. PubMed ID: 22452623
[No Abstract] [Full Text] [Related]
47. TRPM1 (Melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas.
Erickson LA; Letts GA; Shah SM; Shackelton JB; Duncan LM
Mod Pathol; 2009 Jul; 22(7):969-76. PubMed ID: 19396153
[TBL] [Abstract][Full Text] [Related]
48. Chondroid atypical spitzoid melanocytic tumor.
Fernandez-Flores A; Cassarino DS
Rev Esp Patol; 2019; 52(3):190-193. PubMed ID: 31213260
[TBL] [Abstract][Full Text] [Related]
49. Desmoplastic nevus: An entity distinct from spitz nevus and blue nevus.
Sherrill AM; Crespo G; Prakash AV; Messina JL
Am J Dermatopathol; 2011 Feb; 33(1):35-9. PubMed ID: 21124206
[TBL] [Abstract][Full Text] [Related]
50. [Spitz nevus and Reed nevus: simulating melanoma in adults].
Paredes B; Hardmeier T
Pathologe; 1998 Nov; 19(6):403-11. PubMed ID: 9885003
[TBL] [Abstract][Full Text] [Related]
51. A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis.
Kastnerova L; Martinek P; Grossmann P; Steiner P; Vanecek T; Kyclova J; Ferak I; Zalud R; Slehobr O; Svajdler P; Sulc M; Bradamante M; Banik M; Hadravsky L; Sticova E; Hajkova V; Ptakova N; Michal M; Kazakov DV
Am J Dermatopathol; 2020 Aug; 42(8):578-592. PubMed ID: 32701692
[TBL] [Abstract][Full Text] [Related]
52. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.
Da Forno PD; Pringle JH; Fletcher A; Bamford M; Su L; Potter L; Saldanha G
Br J Dermatol; 2009 Aug; 161(2):364-72. PubMed ID: 19438459
[TBL] [Abstract][Full Text] [Related]
53. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
Sarin KY; Sun BK; Bangs CD; Cherry A; Swetter SM; Kim J; Khavari PA
JAMA Dermatol; 2013 Sep; 149(9):1077-81. PubMed ID: 23884457
[TBL] [Abstract][Full Text] [Related]
54. Plexiform spitz nevus: an intradermal spitz nevus with plexiform growth pattern.
Spatz A; Peterse S; Fletcher CD; Barnhill RL
Am J Dermatopathol; 1999 Dec; 21(6):542-6. PubMed ID: 10608247
[TBL] [Abstract][Full Text] [Related]
55. Filigree-like Rete Ridges, Lobulated Nests, Rosette-like Structures, and Exaggerated Maturation Characterize Spitz Tumors With NTRK1 Fusion.
Yeh I; Busam KJ; McCalmont TH; LeBoit PE; Pissaloux D; Alberti L; de la Fouchardière A; Bastian BC
Am J Surg Pathol; 2019 Jun; 43(6):737-746. PubMed ID: 30844834
[TBL] [Abstract][Full Text] [Related]
56. The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation.
Tan JM; Tom LN; Jagirdar K; Lambie D; Schaider H; Sturm RA; Soyer HP; Stark MS
Br J Dermatol; 2018 Jan; 178(1):191-197. PubMed ID: 28714107
[TBL] [Abstract][Full Text] [Related]
57. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
Barnhill RL
Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
[TBL] [Abstract][Full Text] [Related]
58. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
Ko CJ; McNiff JM; Glusac EJ
J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
[TBL] [Abstract][Full Text] [Related]
59. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
Bastian BC
Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
[TBL] [Abstract][Full Text] [Related]
60. The dermal-based borderline melanocytic tumor: a categorical approach.
Magro CM; Crowson AN; Mihm MC; Gupta K; Walker MJ; Solomon G
J Am Acad Dermatol; 2010 Mar; 62(3):469-79. PubMed ID: 20159313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
